Detalhe da pesquisa
1.
Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer.
Acta Oncol
; 60(2): 157-164, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259244
2.
The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer.
Future Oncol
; 15(22): 2561-2569, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31215242